Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pediatrix Medical

14.81
+0.30002.07%
Pre-market: 13.82-0.9900-6.68%04:30 EDT
Volume:501.59K
Turnover:7.39M
Market Cap:1.25B
PE:-12.45
High:14.85
Open:14.27
Low:14.27
Close:14.51
Loading ...

AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza

GlobeNewswire
·
28 Feb

FDA approves ODACTRA® for the treatment of house dust mite allergy in young children

GlobeNewswire
·
28 Feb

MD or HQY: Which Is the Better Value Stock Right Now?

Zacks
·
28 Feb

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

GlobeNewswire
·
26 Feb

MD Gains 11% Since Q4 Earnings Release, Unveils '25 View

Zacks
·
25 Feb

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

Business Wire
·
24 Feb

Pediatrix Medical Group Inc : Mizuho Raises Target Price to $18 From $15

THOMSON REUTERS
·
24 Feb

Dr. Gregory George MD PhD Joins Mesoblast Board

GlobeNewswire
·
24 Feb

Analysts Offer Insights on Healthcare Companies: Icon (ICLR), Pediatrix Medical Group (MD) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
23 Feb

Pediatrix Medical Is Maintained at Hold by Truist Securities

Dow Jones
·
22 Feb

Stock Track | Pediatrix Medical Plummets 5.25% on Analyst Price Target Downgrades

Stock Track
·
21 Feb

Truist Securities Adjusts Pediatrix Medical Group Price Target to $18 From $15, Maintains Hold Rating

MT Newswires Live
·
21 Feb

Pediatrix Medical price target raised to $18 from $15 at Truist

TIPRANKS
·
21 Feb

Deutsche Bank Adjusts Pediatrix Medical Group Price Target to $17 From $15, Maintains Hold Rating

MT Newswires Live
·
21 Feb

Pediatrix Medical Group Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
21 Feb

Pediatrix Medical Group Inc (MD) Q4 2024 Earnings Call Highlights: Strong EBITDA and Strategic ...

GuruFocus.com
·
21 Feb

Stock Track | Pediatrix Medical Soars 10% on Stellar Q4 Earnings Beat, Robust 2025 Guidance

Stock Track
·
20 Feb

Stock Track | Pediatrix Medical Group Soars 8.43% Pre-Market on Upbeat Q4 Results, Solid 2025 Outlook

Stock Track
·
20 Feb

Pediatrix Medical's Q4 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
20 Feb

Pediatrix Medical sees FY25 Adjusted EBITDA $215M-$235M

TIPRANKS
·
20 Feb